Capstone (CAPS) Stock Price, News & Analysis

Company Overview

Capstone Therapeutics Corp., a biotechnology company, develops novel peptides and other molecules for helping patients with under-served medical conditions in the United States. It develops Apo E mimetic peptide molecule AEM-28 and its analogs that have completed Phase Ia and Phase Ib/IIa clinical trials for lipoprotein metabolism. The company was formerly known as OrthoLogic Corp. and changed its name to Capstone Therapeutics Corp. in May 2010. Capstone Therapeutics Corp. was founded in 1987 and is headquartered in Tempe, Arizona.

Key Stats

• Today's Range: $1.98 to $2.09
• 50-Day Range: N/A
• 52-Week Range: $1.65 to $16.18
• Volume: 16,220 shs
• Average Volume: 515,415 shs
• Market Capitalization: $319,160.00
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

CAPS Stock Analysis - Frequently Asked Questions

How have CAPS shares performed this year?

Capstone's stock was trading at $2.40 at the start of the year. Since then, CAPS stock has decreased by 15.8% and is now trading at $2.02.
View the best growth stocks for 2025 here.

When did Capstone IPO?

Capstone (CAPS) raised $5 million in an initial public offering (IPO) on Thursday, March 6th 2025. The company issued 1,250,000 shares at $4.00 per share.

When did Capstone's quiet period expire?

Capstone's quiet period expired on Tuesday, April 15th. Capstone had issued 1,250,000 shares in its IPO on March 6th. The total size of the offering was $5,000,000 based on an initial share price of $4.00. During Capstone's quiet period, underwriters and any insiders involved in the IPO were restricted from issuing any earnings forecasts or research reports for the company because of SEC regulations. Now that the company's quiet period has ended, brokerages that served as underwriters are now able to initiate research on the company.

How do I buy shares of Capstone?

Shares of CAPS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Manufacturing
• Industry: Pharmaceutical Preparations
• Sub-Industry: Pharmaceutical Products
• Current Symbol: NASDAQ:CAPS
• CIK: 887151
• Web: N/A
• Phone: (708) 371-0660
• Fax: N/A
• Employees: 38
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: $44.05 million
• Price / Sales: 0.01
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 158,000
• Free Float: N/A
• Market Cap: $319,160.00
• Optionable: N/A
• Beta: -0.79